If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Donald A. Zakrowski net worth and biography

Donald Zakrowski Biography and Net Worth

CAO of Eli Lilly and

The estimated Net Worth of Donald A Zakrowski is at least $3.57 Million dollars as of 28 April 2021. Mr Zakrowski owns over 3,000 units of Lilly(Eli) & Co stock worth over $1,332,287 and over the last 9 years he sold LLY stock worth over $2,241,355.

Mr has made over 18 trades of the Lilly(Eli) & Co stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 3,000 units of LLY stock worth $544,140 on 28 April 2021.

The largest trade he's ever made was selling 3,700 units of Lilly(Eli) & Co stock on 2 March 2020 worth over $473,600. On average, Mr trades about 896 units every 106 days since 2012. As of 28 April 2021 he still owns at least 5,987 units of Lilly(Eli) & Co stock.

What is Donald A. Zakrowski's net worth?: The estimated net worth of Donald A. Zakrowski is at least $2.15 million as of June 1st, 2022. Mr. Zakrowski owns 6,274 shares of Eli Lilly and stock worth more than $2,154,617 as of April 1st. This net worth estimate does not reflect any other investments that Mr. Zakrowski may own. Learn More about Donald A. Zakrowski's net worth.
How do I contact Donald A. Zakrowski?: The corporate mailing address for Mr. Zakrowski and other Eli Lilly and executives is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. Eli Lilly and can also be reached via phone at (317) 276-2000 and via email at [email protected] Learn More on Donald A. Zakrowski's contact information.
Has Donald A. Zakrowski been buying or selling shares of Eli Lilly and?: Donald A. Zakrowski has not been actively trading shares of Eli Lilly and during the last ninety days. Most recently, Donald A. Zakrowski sold 1,000 shares of the business's stock in a transaction on Wednesday, June 1st. The shares were sold at an average price of $313.44, for a transaction totalling $313,440.00. Following the completion of the sale, the chief accounting officer now directly owns 6,274 shares of the company's stock, valued at $1,966,522.56. Learn More on Donald A. Zakrowski's trading history.
Who are Eli Lilly and's active insiders?: Eli Lilly and's insider roster includes Anat Ashkenazi (Sr. VP & CFO ), Melissa Barnes (SVP), Enrique Conterno (SVP), Stephen Fry (SVP), Michael Harrington (VP), Susan Mahony (SVP), Myles O'Neill (SVP), Derica Rice (EVP), David Ricks (CEO), Marschall Runge (Director), Aarti Shah (SVP), Christi Shaw (SVP), Jeffrey Simmons (SVP), Daniel Skovronsky (SVP), Joshua Smiley (CFO), Jackson Tai (Director), Jacob Van Naarden (Sr. VP), Alonzo Weems (SVP), Anne White (SVP), Ilya Yuffa (SVP), Donald Zakrowski (CAO), and Alfonso Zulueta (SVP). Learn More on Eli Lilly and's active insiders.
Are insiders buying or selling shares of Eli Lilly and?: In the last year, Eli Lilly and insiders bought shares 2 times. They purchased a total of 29,993,324 shares worth more than $375,107,898.64. In the last year, insiders at the sold shares 33 times. They sold a total of 2,417,103 shares worth more than $780,173,002.61. The most recent insider tranaction occured on March, 24th when Major Shareholder Lilly Endowment Inc sold 200,000 shares worth more than $67,164,000.00. Insiders at Eli Lilly and own 0.1% of the company. Learn More about insider trades at Eli Lilly and.
Information on this page was last updated on 3/24/2023.

Donald A. Zakrowski Insider Trading History at Eli Lilly and

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/1/2022	Sell	1,000	$313.44	$313,440.00	6,274
2/25/2022	Sell	1,660	$243.84	$404,774.40
4/28/2021	Sell	3,000	$181.38	$544,140.00	5,987
3/22/2019	Sell	1,000	$128.50	$128,500.00
3/1/2019	Sell	1,000	$127.01	$127,010.00
9/4/2018	Sell	600	$105.57	$63,342.00	3,530
3/1/2018	Sell	860	$76.50	$65,790.00
2/21/2018	Sell	876	$77.55	$67,933.80	4,130
2/5/2018	Sell	900	$81.09	$72,981.00	4,130
2/2/2017	Sell	2,000	$77.52	$155,040.00	886
7/28/2016	Sell	1,213	$83.16	$100,873.08	1,300
5/2/2016	Sell	1,600	$75.86	$121,376.00	3,113

Donald A. Zakrowski Buying and Selling Activity at Eli Lilly and

Eli Lilly and Company Overview

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Today's Range

Now: $343.42

$340.69

$343.65

50 Day Range

MA: $331.96

$310.63

$350.40

2 Week Range

Now: $343.42

$276.83

$384.44

Volume

2,933,578 shs

Average Volume

3,572,727 shs

Market Capitalization

$326.35 billion

P/E Ratio

49.77

Dividend Yield

1.35%

Beta

0.36

The Safest Option in Trades!

From Tradewins | Ad

Click here now!